Welcome to LookChem.com Sign In|Join Free
  • or
2-Bromo-5-(methoxymethyl)thiophene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

82830-92-0

Post Buying Request

82830-92-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

82830-92-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 82830-92-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,8,3 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 82830-92:
(7*8)+(6*2)+(5*8)+(4*3)+(3*0)+(2*9)+(1*2)=140
140 % 10 = 0
So 82830-92-0 is a valid CAS Registry Number.

82830-92-0Downstream Products

82830-92-0Relevant academic research and scientific papers

ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES

-

Page/Page column 92, (2014/01/09)

The invention provides compounds of formula la, lb and Ic: [Formula Ia, Ib, and Ic] and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.

INDOLE CARBOXAMIDES AS IKK2 INHIBITORS

-

, (2008/12/04)

The invention is directed to novel indole carboxamide compounds. Specifically, the invention is directed to compounds according to formula (I): wherein R1, R2, R3, R4, and m are as defined herein. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, such as rheumatoid arthritis, asthma, rhinitis, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 82830-92-0